ClinVar Miner

Submissions for variant GRCh37/hg19 19p13.2(chr19:13427805-13682946)x1

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Quest Diagnostics Nichols Institute San Juan Capistrano RCV002472568 SCV002772436 likely pathogenic not provided 2021-09-09 criteria provided, single submitter clinical testing The copy number loss of 19p13.2 includes multiple exons (NM_001127221.2) of the 5' portion of CACNA1A (OMIM 601011). Haploinsufficiency of CACNA1A is associated with autosomal dominant episodic ataxia (OMIM 108500), a neurologic condition characterized by spells of incoordination and imbalance, often associated with progressive ataxia. Intragenic/exonic deletions have been reported in numerous individuals and families with episodic ataxia 2 (Damaj 2015, Wan 2011, Labrum 2009). Additionally, there is a larger copy number loss of this region (esv34036) in the general populations of the Database of Genomic Variants. Thus, based on size, literature review and gene content, this copy number gain is interpreted as likely pathogenic. References: Damaj et al., Eur J Hum Genet. 2015 Nov;23(11):1505-12. PMID: 25735478 Labrum et al., J Med Genet. 2009 Nov;46(11):786-91. PMID: 19586927 Wan et al., Front Neurol. 2011 Sep 9;2:51. PMID: 21927611

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.